• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1 Back to Search Results
Model Number 806455
Medical Device Problem Code Mechanical Problem (1384)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/29/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that during use of the device for cardiopulmonary bypass (cpb), the venous occluder head did not fully occlude allowing flow to pass through.As mitigation, manual tube clamps were used.The surgical procedure was completed successfully.There was no delay, no blood loss, nor adverse consequences to the patient.
 
Additional Manufacturer Narrative
Evaluation is in progress, but not yet concluded.
 
Additional Manufacturer Narrative
The reported complaint was confirmed.The service repair technician (srt) could not duplicate the reported issue.The unit operated to the manufacturer's specifications.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Additional Manufacturer Narrative
Updated block: b5.During laboratory analysis, the product surveillance technician (pst) connected the occluder head to lab use only (luo) testing equipment.The occluder passed all verification/release testing.The pst ran the occluder for 16.5 hours and verified that no water passed through the tube when in it was in one meter of water above the occluder.It was determined that the occluder met specification.
 
Event or Problem Description
Per clinical review: on (b)(6) 2022, the team experienced a problem with their heart lung machine (hlm) venous occluder immediately prior to initiating cardiopulmonary bypass (cpb), whereby the occluder was allowing flow to pass when it was closed all the way.The user noticed this as the surgeon connected the venous line and removed the tubing clamp at the field, and the situation was immediately remedied by using a tubing clamp to clamp the venous line.Therefore, there was no delay, no blood loss, and no adverse event reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANCED PERFUSION SYSTEM 1
Common Device Name
CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
6200 jackson road
ann arbor MI 48103
Manufacturer (Section G)
SAME
Manufacturer Contact
douglas patton
6200 jackson road
ann arbor, MI 48103
7346634145
MDR Report Key15475757
Report Number1828100-2022-00336
Device Sequence Number12267168
Product Code DTQ
UDI-Device Identifier00886799000878
UDI-Public(01)00886799000878(11)170622
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
K172220
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number806455
Device Catalogue Number806455
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/01/2022
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/29/2022
Supplement Date Received by Manufacturer09/30/2022
11/02/2022
Initial Report FDA Received Date09/24/2022
Supplement Report FDA Received Date10/21/2022
11/15/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/22/2017
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Patient SexUnknown
-
-